Advertisement
Advertisement
Operol

Operol

propofol

Manufacturer:

Medhaus

Distributor:

Medhaus
Concise Prescribing Info
Contents
Propofol
Indications/Uses
Initiation & maintenance of monitored anesth care (MAC) sedation, combined sedation & regional anesth, ICU sedation of intubated, mechanically ventilated patients in adults only. Induction & maintenance of general anaesth for patients ≥3 yr.
Dosage/Direction for Use
Induction of general anesth Adult <55 yr 2-2.5 mg/kg. Elderly, debilitated, ASA-PS III or IV patients 1-1.5 mg/kg. Cardiac anesth 0.5-1.5 mg/kg. Neurological patient 1-2 mg/kg. Maintenance of general anesth Infusion Adult <55 yr 6-12 mg/kg/hr. Elderly, debilitated, ASA-PS III or IV patient 3-6 mg/kg/hr. Cardiac anesth: 100-150 mcg/kg/min as primary inj emulsion w/ secondary opioid; 50-100 mcg/kg/min for low-dose propofol inj emulsion w/ primary opioid. Neurological patient 6-12 mg/kg/hr. Pediatric 2 mth-16 yr 7.5-18 mg/kg/hr. Intermittent bolus Adult <55 yr 20-50 mg. Initiation of MAC sedation Adult <55 yr 6-9 mg/kg/h infusion for 3-5 min or 0.5 mg/kg slow inj for 3-5 min. Maintenance of MAC sedation Adult <55 yr 1.5-4.5 mg/kg/hr infusion or 10 or 20 mg incremental bolus. Elderly, debilitated, ASA-PS III or IV patient 80% of usual adult dose. Initiation & maintenance of ICU sedation of intubated, mechanically ventilated Adult Initially 5 mcg/kg/min for at least 5 min. Subsequent increments of 5-10 mcg/kg/min for 10-15 min. Maintenance rate: 5-50 mcg/kg/min.
Contraindications
Hypersensitivity. Allergy to eggs, egg products, soybeans & soy products. Patients w/ history of epilepsy & seizure. Pregnancy & lactation.
Special Precautions
Monitor for early signs of hypotension, bradycardia, CV depression, apnea, airway obstruction &/or oxygen desaturation. Debilitated or ASA-PSIII or IV patients. Patients w/ lipid metabolism disorder eg, primary hyperlipoproteinemia, diabetic hyperlipidemia & pancreatitis. Risk of seizure in epileptic patient. Avoid rapid bolus administration. Abrupt discontinuation may result in rapid awakening w/ associated anxiety, agitation & resistance to mechanical ventilation. Renal failure &/or hepatic insufficiency. Elderly. Pregnancy & lactation.
Adverse Reactions
Anesth/MAC sedation: Bradycardia, bradycardia arrhythmia, tachycardia nodal, hypotension, decreased cardiac output; movement; apnea, rash; hypersalivation; diplopia, ear & eye pain, nystagmus, taste perversion, tinnitus; hives/itching, phlebitis, redness/discoloration. ICU sedation: Bradycardia, decreased cardiac output, agitation, resp acidosis during weaning.
Drug Interactions
May increase anesth or sedative effects w/ narcotics (eg, morphine, meperidine, fentanyl), opioids & sedatives (eg, benzodiazepines, barbiturates, chloral hydrate, droperidol). Supplemental analgesics (eg, nitrous oxide or opioids). May increase the anesth or sedative & cardioresp effects w/ potent inhalational agents (eg, isoflurane, enflurane & halothane). Serious bradycardia w/ prenatal inj emulsion in ped patients.
MIMS Class
Anaesthetics - Local & General
ATC Classification
N01AX10 - propofol ; Belongs to the class of other general anesthetics.
Presentation/Packing
Form
Operol emulsion for inj 10 mg/mL
Packing/Price
20 mL x 1's (P500/vial)
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement